MILAD RIAZIFAR

Milad Riazifar is a biomedical researcher specializing in stem cell biology and exosome therapeutics, though his current professional role and geographic location remain undisclosed. He earned his doctorate from the Stem Cell Research Center at the University of California Irvine, where he researched and pioneered early cell-free, exosome-based treatments targeting multiple sclerosis. Riazifar subsequently transitioned to gain clinical translation experience at City of Hope, a prominent clinical research center. There, he contributed to the scientific team that initiated the first human clinical trial utilizing stem cell exosomes for the treatment of type 1 diabetes. His scientific career encompasses more than a decade of stem cell research, featuring a dedicated focus on exosome science that began in 2012. Riazifar's current focus remains the advancement of regenerative medicine and the clinical translation of cell-free therapeutics for chronic autoimmune diseases.